Cargando…

Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes

[Image: see text] Fluorine-18 is the most frequently used radioisotope in positron emission tomography (PET) radiopharmaceuticals in both clinical and preclinical research. Its physical and nuclear characteristics (97% β(+) decay, 109.7 min half-life, 635 keV positron energy), along with high specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Orit, Kiesewetter, Dale O., Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306521/
https://www.ncbi.nlm.nih.gov/pubmed/25473848
http://dx.doi.org/10.1021/bc500475e
_version_ 1782354338164768768
author Jacobson, Orit
Kiesewetter, Dale O.
Chen, Xiaoyuan
author_facet Jacobson, Orit
Kiesewetter, Dale O.
Chen, Xiaoyuan
author_sort Jacobson, Orit
collection PubMed
description [Image: see text] Fluorine-18 is the most frequently used radioisotope in positron emission tomography (PET) radiopharmaceuticals in both clinical and preclinical research. Its physical and nuclear characteristics (97% β(+) decay, 109.7 min half-life, 635 keV positron energy), along with high specific activity and ease of large scale production, make it an attractive nuclide for radiochemical labeling and molecular imaging. Versatile chemistry including nucleophilic and electrophilic substitutions allows direct or indirect introduction of (18)F into molecules of interest. The significant increase in (18)F radiotracers for PET imaging accentuates the need for simple and efficient (18)F-labeling procedures. In this review, we will describe the current radiosynthesis routes and strategies for (18)F labeling of small molecules and biomolecules.
format Online
Article
Text
id pubmed-4306521
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-43065212015-12-04 Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes Jacobson, Orit Kiesewetter, Dale O. Chen, Xiaoyuan Bioconjug Chem [Image: see text] Fluorine-18 is the most frequently used radioisotope in positron emission tomography (PET) radiopharmaceuticals in both clinical and preclinical research. Its physical and nuclear characteristics (97% β(+) decay, 109.7 min half-life, 635 keV positron energy), along with high specific activity and ease of large scale production, make it an attractive nuclide for radiochemical labeling and molecular imaging. Versatile chemistry including nucleophilic and electrophilic substitutions allows direct or indirect introduction of (18)F into molecules of interest. The significant increase in (18)F radiotracers for PET imaging accentuates the need for simple and efficient (18)F-labeling procedures. In this review, we will describe the current radiosynthesis routes and strategies for (18)F labeling of small molecules and biomolecules. American Chemical Society 2014-12-04 2015-01-21 /pmc/articles/PMC4306521/ /pubmed/25473848 http://dx.doi.org/10.1021/bc500475e Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Jacobson, Orit
Kiesewetter, Dale O.
Chen, Xiaoyuan
Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title_full Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title_fullStr Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title_full_unstemmed Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title_short Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
title_sort fluorine-18 radiochemistry, labeling strategies and synthetic routes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306521/
https://www.ncbi.nlm.nih.gov/pubmed/25473848
http://dx.doi.org/10.1021/bc500475e
work_keys_str_mv AT jacobsonorit fluorine18radiochemistrylabelingstrategiesandsyntheticroutes
AT kiesewetterdaleo fluorine18radiochemistrylabelingstrategiesandsyntheticroutes
AT chenxiaoyuan fluorine18radiochemistrylabelingstrategiesandsyntheticroutes